# 1. Financial Performance ## A. Key Figures * **Revenue Growth:** **17.6%** Q4 YoY (5-year high) · **13%** Full Year * **EBITDA:** **17.2%** Q4 Growth · **15.8%** FY Growth · **20.4%** FY Margin * **EBIT:** **18%** FY Growth · **12.3%** FY Margin (+50 bps) * **PAT:** **15%** FY Growth · **1%** Q4 Growth (ex-exceptional) * **Returns & Leverage:** **19%** ROCE (+96 bps) · **0.52x** Net Debt/EBITDA ## B. Revenue & Profitability Trends * **Consistent Top-line Momentum:** Achieved a fourth consecutive quarter of double-digit expansion, driven by strategic execution rather than transitory geopolitical or tariff-related factors. * **Sustained Margin Profile:** Operating margins remained above the 20% threshold for the seventh straight quarter, supported by scale benefits and efficiency projects. * **Regional Margin Headwinds:** AMESA bottom-line performance was dampened by **CEO transition costs** and a high base effect, though structural margins remained resilient. * **Pricing Discipline:** Institutionalized monthly gross contribution reviews allow for proactive price adjustments, ensuring no significant lag in cost recovery for non-contractual clients. * **Depreciation Impact:** EBIT margins faced optical pressure from currency translation and a **INR 385 Cr** annual depreciation charge following large equipment capitalization in Q4. ## C. Balance Sheet & Capital Allocation * **Deleveraging & Liquidity:** Strong cash flow generation has reinforced a healthy balance sheet, maintaining a low debt ratio to support organic and inorganic pursuits. * **Dividend Suspension:** Payouts are temporarily halted to preserve the valuation construct of the **proposed merger and share swap**; dividends are expected to resume post-integration. * **Funding Strategy:** Capex remains entirely organically funded, with a clear priority on using excess cash for debt reduction and growth investments. --- # 2. Operating Segments ## A. Key Figures * **Segment Growth (YoY):** **30%** Beauty & Cosmetics · **10%** Oral Care * **Revenue Mix:** **47%** Oral Care · **40%** Beauty & Cosmetics · **53%** Personal Care & Beyond * **B&C Margin:** **20.4%** (+50 bps) * **Regional Growth (YoY):** **25%** EAP · **24.1%** Americas · **15.5%** Europe · **10.4%** AMESA ## B. Beauty & Cosmetics (B&C) * **Dominant Growth Engine:** Achieved a fourth consecutive quarter of high double-digit growth, now surpassing Oral Care in scale across most key markets. * **Strategic Premiumization:** Momentum driven by increased participation in the **extrusion segment** and proactive capex investments in innovation and backend capabilities. * **Investment Philosophy:** Management prioritizes "good costs" (front-line resourcing) over immediate margin spikes to ensure gradual, sustained profitability improvements. ## C. Oral Care * **Core Stability:** Remains the foundational revenue pillar, benefiting from a healthy recovery and strong global customer relationships. * **Portfolio Diversification:** While Oral Care saw a return to growth, the broader portfolio shift toward Personal Care has successfully mitigated previous category headwinds. ## D. Regional Performance * **Geographic Breadth:** Performance was broad-based with double-digit expansion across all sectors, led by exceptional results in EAP and the Americas. * **Americas Momentum:** Growth highlighted by a "blockbuster" performance in **Brazil**, expanding from a single client to a multi-customer base over **three years**. * **EAP & AMESA Drivers:** EAP strength was fueled by the China core market, while AMESA growth was supported by an **11.5%** uptick in India stand-alone operations. * **Future Capacity:** The new **Thailand plant** (established November) is currently in the customer validation phase and represents a future revenue catalyst. --- # 3. Manufacturing & Capacity ## A. Key Figures * **Annual Capex:** **₹480 Cr** Total Investment · **$5M** Thailand Greenfield * **Depreciation:** **₹385 Cr** * **B&C Segment Growth:** **30%** ## B. Thailand Plant & Market Expansion * **Strategic Market Entry:** Thailand identified as a high-potential Beauty & Cosmetics (B&C) hub; operations are currently focused on customer validation and certification following the **November** launch. * **Volume Outlook:** Management expects a gradual scale-up in volumes over the next few quarters, mirroring the successful growth trajectory observed in the outperforming Brazil market. * **White Space Strategy:** Beyond current facilities, the company is actively exploring new geographic "white spaces" to sustain its emerging market momentum. ## C. Capex Investments & Production Scaling * **Front-Loaded Investment:** Annual capital expenditure significantly exceeded depreciation, reflecting a heavy focus on expanding the B&C segment across all product lines. * **FY27 Investment Horizon:** Capex is expected to remain at elevated levels through the next fiscal year to bolster capacity, innovation, and operational flexibility. * **Market Share Capture:** Aggressive investment strategy is specifically designed to capitalize on the robust double-digit growth within the global Beauty & Cosmetics category. --- # 4. M&A & Partnerships ## A. Key Figures * **Target Platform Scale:** **~$1 Billion** Combined consumer packaging entity * **Indovida Growth Profile:** **High single-digit** Steady-state revenue growth * **Regulatory Timeline:** **~12 Months** Expected completion by **Q4 FY '27** ## B. Indovida Merger * **Strategic Transformation:** Proposed merger creates a massive global platform, leveraging Indovida’s leading market positions to drive faster growth and margin accretion. * **Financial Synergy:** The deal is expected to strengthen the balance sheet as the target is **debt-free**, enhancing the combined entity's future deal-making capacity. * **Immediate P&L Impact:** All transaction-related expenses have been fully recognized within the current quarter. ## C. Inorganic Strategy * **Core Growth Pillars:** Management is aggressively pursuing acquisitions that offer new geographic reach or technical capabilities, specifically targeting the **Beauty & Cosmetics (B&C)** sector. * **Disciplined Expansion:** Future M&A remains focused on targets that are growth and margin accretive while maintaining a **low debt-to-EBITDA ratio**. * **Ecosystem Leverage:** The company is utilizing the **IVL Group’s** industry capabilities to accelerate the identification and execution of strategic opportunities. ## D. Regulatory Timeline * **Approval Status:** Filings have been initiated with **SEBI, CCI, and international antitrust** bodies to expedite the integration process. * **Operational Ringfencing:** Both entities must remain strictly independent with no information sharing until final regulatory clearance is secured. * **Data Restrictions:** Management is withholding specific market share and category-level performance data for the target until the merger is finalized. --- # 5. Demand & Pricing ## A. Key Figures * **Contractual Coverage:** **>50%** of total business under pass-through agreements ## B. Pass-through Mechanisms * **EBITDA Protection:** Contractual arrangements utilize a **landed cost plus power** mechanism to insulate absolute earnings from raw material, logistics, and currency volatility. * **Comprehensive Recovery:** Management expresses high confidence in recovering all additional costs from both contractual and non-contractual segments despite ongoing market inflation. * **Geopolitical Mitigation:** Pass-through structures are being actively leveraged to neutralize the impact of the Middle East crisis on input costs and availability. ## C. Pricing Strategy & Agility * **Proactive Market Adjustments:** For the non-contractual portion of the portfolio, the company is aggressively seeking price hikes to offset rising energy and logistics costs, with a specific focus on **Europe**. * **Zero-Lag Recovery:** Management anticipates full recovery of West Asia crisis-related cost spikes without traditional timing lags through proactive pricing actions. * **Enhanced Operational Rigor:** Leadership has shifted to **weekly or higher frequency** pricing reviews to maintain the agility required to absorb and pass on rapid cost fluctuations. ## D. Contractual Mix * **Structural Resilience:** The business model has been significantly de-risked since the pandemic, with a majority of the revenue base now secured by formal pass-through clauses. --- # 6. Risks & Supply Chain ## A. Key Figures * Input Cost Inflation: 20% inflation assumed in raw materials * **Inventory Coverage:** Secured through **mid-July** ## B. Raw Material & Supply Chain Dynamics * **Inflationary Pressure:** Significant COGS impact from rising input costs is influencing broader pricing strategies and growth projections. * **Procurement Volatility:** Global pricing and availability remain highly unstable, fluctuating on a **weekly basis** across key regions including India, China, Europe, and the U.S. * **Agile Inventory Strategy:** Supply chain risks are being mitigated through aggressive inventory expansion and leveraging scale with long-standing partners to ensure material availability. ## C. Geopolitical Exposure * **Regional Resilience:** Underlying growth in the AMESA region remains largely insulated from the ongoing Middle East crisis. --- # 7. Guidance & Outlook ## A. Key Figures * **Revenue Growth Guidance:** **11% to 13%** Long-term/FY range (vs. **13%** current FY delivery) * **EBITDA Growth Guidance:** **>11% to 13%** Expected to slightly exceed revenue growth * **Effective Tax Rate (ETR):** **18%** Current FY · **18% to 22%** Steady-state guidance ## B. Revenue & Margin Outlook * **Conservative Growth Targets:** Management maintains low double-digit revenue guidance despite potential tailwinds from the Thailand plant ramp-up and the **Beauty & Cosmetics** segment. * **Macro Volatility:** Quarterly performance remains subject to fluctuations driven by **volatile pricing** and rising costs linked to geopolitical tensions in the **Middle East**. * **Guidance Scope:** Current growth projections apply strictly to the **standalone entity**; consolidated guidance is deferred until the merger process concludes. * **Tax Rate Dynamics:** Future ETR will fluctuate within a 400 bps range based on the geographical earnings mix, with regional rates varying from **0% to 35%**. ## C. Long-term Strategy * **Market Share Gains:** Supply chain resilience during raw material shortages is being leveraged as a primary competitive advantage to capture market share. * **Regional Optimism:** Growth in FY27 is expected to be anchored by the **AMESA region and India**, supported by a recovery in **Oral Care** and sustained **Beauty & Cosmetics** momentum. * **Strategic Alignment:** Management reaffirms that the pending merger is a core component of the long-term strategy to sustain historical performance levels.